Literature DB >> 22328841

Major histocompatibility complex class i and tumour immuno-evasion: how to fool T cells and natural killer cells at one time.

D Fruci1, M Benevolo, L Cifaldi, S Lorenzi, E Lo Monaco, E Tremante, P Giacomini.   

Abstract

Entities:  

Year:  2012        PMID： 22328841      PMCID： PMC3267590          DOI： 10.3747/co.19.945

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  27 in total

Review 1.  A structural perspective on MHC class Ib molecules in adaptive immunity.

Authors:  Lucy C Sullivan; Hilary L Hoare; James McCluskey; Jamie Rossjohn; Andrew G Brooks
Journal:  Trends Immunol       Date:  2006-07-21       Impact factor: 16.687

2.  Expression of endoplasmic reticulum aminopeptidases in EBV-B cell lines from healthy donors and in leukemia/lymphoma, carcinoma, and melanoma cell lines.

Authors:  Doriana Fruci; Silvia Ferracuti; Maria Zaira Limongi; Veronica Cunsolo; Ezio Giorda; Rocco Fraioli; Leonardo Sibilio; Oliver Carroll; Akira Hattori; Peter M van Endert; Patrizio Giacomini
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

Review 3.  Biology and functions of human leukocyte antigen-G in health and sickness.

Authors:  J LeMaoult; M Le Discorde; N Rouas-Freiss; P Moreau; C Menier; J McCluskey; E D Carosella
Journal:  Tissue Antigens       Date:  2003-10

4.  Association of antigen-processing machinery and HLA antigen phenotype of melanoma cells with survival in American Joint Committee on Cancer stage III and IV melanoma patients.

Authors:  Andrea Anichini; Roberta Mortarini; Daisuke Nonaka; Alessandra Molla; Claudia Vegetti; Elisabetta Montaldi; Xinhui Wang; Soldano Ferrone
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

5.  Low prevalence of selective human leukocyte antigen (HLA)-A and HLA-B epitope losses in early-passage tumor cell lines.

Authors:  P Giacomini; E Giorda; R Fraioli; M R Nicotra; N Vitale; A Setini; L Delfino; A Morabito; M Benevolo; I Venturo; M Mottolese; G B Ferrara; P G Natali
Journal:  Cancer Res       Date:  1999-06-01       Impact factor: 12.701

6.  HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.

Authors:  Takeshi Ogino; Hiroshi Shigyo; Hideyuki Ishii; Akihiro Katayama; Naoyuki Miyokawa; Yasuaki Harabuchi; Soldano Ferrone
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

7.  Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.

Authors:  P Tomasec; V M Braud; C Rickards; M B Powell; B P McSharry; S Gadola; V Cerundolo; L K Borysiewicz; A J McMichael; G W Wilkinson
Journal:  Science       Date:  2000-02-11       Impact factor: 47.728

8.  Analysis of HLA-E expression in human tumors.

Authors:  Rosario Marín; Francisco Ruiz-Cabello; Susana Pedrinaci; Rosa Méndez; Pilar Jiménez; Daniel E Geraghty; Federico Garrido
Journal:  Immunogenetics       Date:  2003-01-30       Impact factor: 2.846

9.  The antigen processing machinery of class I human leukocyte antigens: linked patterns of gene expression in neoplastic cells.

Authors:  Ezio Giorda; Leonardo Sibilio; Aline Martayan; Sara Moretti; Irene Venturo; Marcella Mottolese; Giovan Battista Ferrara; Sandra Cappellacci; Laura Eibenschutz; Caterina Catricalà; Paola Grammatico; Patrizio Giacomini
Journal:  Cancer Res       Date:  2003-07-15       Impact factor: 12.701

10.  High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis.

Authors:  Maria Benevolo; Marcella Mottolese; Elisa Tremante; Francesca Rollo; Maria Grazia Diodoro; Cristiana Ercolani; Isabella Sperduti; Elisa Lo Monaco; Maurizio Cosimelli; Patrizio Giacomini
Journal:  J Transl Med       Date:  2011-10-27       Impact factor: 5.531
View more
  15 in total

Review 1.  Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?

Authors:  Rakesh R Ramjiawan; Arjan W Griffioen; Dan G Duda
Journal:  Angiogenesis       Date:  2017-03-30       Impact factor: 9.596

Review 2.  Immune surveillance in melanoma: From immune attack to melanoma escape and even counterattack.

Authors:  Fade Mahmoud; Bradley Shields; Issam Makhoul; Nathan Avaritt; Henry K Wong; Laura F Hutchins; Sara Shalin; Alan J Tackett
Journal:  Cancer Biol Ther       Date:  2017-05-17       Impact factor: 4.742

3.  Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression.

Authors:  R J Seager; Cynthia Hajal; Fabian Spill; Roger D Kamm; Muhammad H Zaman
Journal:  Converg Sci Phys Oncol       Date:  2017-07-28

Review 4.  Functional genomics: paving the way for more successful cancer immunotherapy.

Authors:  Reham Ajina; Danielle Zamalin; Louis M Weiner
Journal:  Brief Funct Genomics       Date:  2019-03-22       Impact factor: 4.241

Review 5.  Molecular imaging biomarkers for cell-based immunotherapies.

Authors:  Mohammad Haris; Puneet Bagga; Hari Hariharan; Bevin McGettigan-Croce; Laura A Johnson; Ravinder Reddy
Journal:  J Transl Med       Date:  2017-06-19       Impact factor: 5.531

Review 6.  New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer.

Authors:  Anushka Dongre; Robert A Weinberg
Journal:  Nat Rev Mol Cell Biol       Date:  2019-02       Impact factor: 94.444

7.  T and NK cells: two sides of tumor immunoevasion.

Authors:  Doriana Fruci; Elisa Lo Monaco; Loredana Cifaldi; Franco Locatelli; Elisa Tremante; Maria Benevolo; Patrizio Giacomini
Journal:  J Transl Med       Date:  2013-02-04       Impact factor: 5.531

8.  Genome-wide association study of antibody response to Newcastle disease virus in chicken.

Authors:  Chenglong Luo; Hao Qu; Jie Ma; Jie Wang; Chunyu Li; Chunfen Yang; Xiaoxiang Hu; Ning Li; Dingming Shu
Journal:  BMC Genet       Date:  2013-05-10       Impact factor: 2.797

9.  A phase I clinical trial of adoptive transfer of folate receptor-alpha redirected autologous T cells for recurrent ovarian cancer.

Authors:  Lana E Kandalaft; Daniel J Powell; George Coukos
Journal:  J Transl Med       Date:  2012-08-03       Impact factor: 5.531

Review 10.  Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy.

Authors:  Ruan F V Medrano; Aline Hunger; Samir Andrade Mendonça; José Alexandre M Barbuto; Bryan E Strauss
Journal:  Oncotarget       Date:  2017-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.